Immune Deficiency Clinical Trial
Official title:
Feasibility, Acceptability and Satisfaction of a New Device (Buzzy®) for Pediatric Procedural Pain and Anxiety Management During Needle-Related Procedures: A Pilot Study.
Needle-related procedures are the most important source of pain and anxiety in pediatric
patients. Consequently, needle-phobia and anxiety are common in children with auto-immune
disease and immune deficiency and may be barriers to adherence in treatment. The use of a
non-pharmacological and easy-to-use approach, like the Buzzy® device, could be an alternative
or adjuvant for the management of procedural pain and anxiety of these children during
needle-related procedures.
This study aims to determine the feasibility, acceptability and satisfaction of the Buzzy®
device for procedural pain and anxiety relief of immunology-rheumatology patients undergoing
needle-related procedures. The investigators will compare the Buzzy® device with an
anaesthetic cream (Maxilene®) during needle-related procedures. The investigators also plan
to assess feasibility outcomes and satisfaction of the nurses and the children with the use
of the Buzzy® device. This pilot study should refine or modify the research methodology and
improve the intervention being piloted before it's efficacy will be verified within a larger
scale-study.
The investigators strongly believe that the use of the Buzzy® device in immunology
rheumatology department could optimise procedural pain and anxiety management. Since most of
the treatments administered for auto-immune diseases and immune deficiency diseases are
through subcutaneous or intramuscular injections, pain and anxiety management using
non-pharmacological and/or pharmacological interventions should be prioritized. Given this
knowledge, the investigators feel that this pilot study has the potential to contribute to
pain and anxiety management of children undergoing needle-related procedures.
Rationale: Procedural pain and anxiety relief of needle-related procedures is a major concern
for nurses working with Immunology-Rheumatology patients. Treatments for most autoimmune
diseases and immune deficiencies diseases are administrated by subcutaneous or intramuscular
injections and these children will go through countless needle-related procedures for a long
period of their life. Procedural pain and anxiety generates consequences which may be
physiological, psychological and emotional. Since it is impossible to completely control pain
and anxiety experienced by pediatric patients during painful procedures, non-pharmacological
and/or pharmacological interventions should be part of the interventions to provide comfort
to children. Interventions to decrease physical and emotional impacts of needle-related
procedures should be an integral part of nursing activities. Most of pain and anxiety
management methods available for children require much time of staff, which represents
barriers to their implantation among nursing interventions. Use of a rapid and easy-to-use
non-pharmacological intervention could overcome these constraints and optimise pain and
anxiety relief in children. Investigators believe that the Buzzy® device, combining cold and
vibration, could be an efficient way to improve pain and anxiety management during
needle-related procedures. To date, no studies have focused on the efficacy of this device on
pediatric immunology-rheumatology patients.
Objective: To assess the feasibility, acceptability and satisfaction of a new device (Buzzy®)
combining the effect of cold and vibration, for procedural pain relief and anxiety during
needle-related procedures in pediatric immunology-rheumatology patients.
Methods. Design: This study is a pilot study of a two-group randomized controlled trial
(RCT). Setting: Immunology-Rheumatology clinic of the CHU Sainte-Justine's (Montreal).
Inclusion criteria: We will include children: a) between the ages of 4 and 17 years old; b)
visiting the Immunology-Rheumatology Clinic for a follow-up; c) who require a s/c injection
or IM injection or venipuncture or IV catheter insertion; d) who understand French or
English; e) who have at least one parent who understand, read and talk French or English.
Exclusion criteria: We will exclude children: a) who have a diagnosed neuro-cognitive
disability that precludes patients from assenting and participating to the study, b) who have
the inability to self-report pain. Sample size: We expect to recruit 100 participants for
this pilot study (50 participants per group). Allocations: According to a randomized list,
patients will be allocated to one of the study group: a) Experimental group: Just before the
needle-related procedure, the Buzzy® device, combining an ice pack and vibration integrated
to a plastic bee, will be applied 5 cm above the needle insertion site and will be maintained
in place throughout the painful procedure; or b) Control group: Maxilene® topical anaesthetic
cream will be applied 30 minutes before the needle-related procedure on the insertion site.
Primary outcomes: Post-procedural pain and it will be measured with the Faces Pain
Scale-Revised (FPS-R) (4-12 years old) and the Numerical Pain Rating Scale (NPRS) (>12 years
old). Secondary outcomes: Post-procedural anxiety and it will be measured with the Procedure
Behavior Check List (PBCL). We will also assess the satisfaction of nurses and children
regarding the Buzzy® device. Satisfaction will be measured using questionnaires previously
developed by investigators. The principal feasibility outcomes will be the recruitment rates,
the refusal rate, the needle-related procedure rate and the time of the procedure. Study
times periods: Four study times periods are planned: T-0: before randomization; T-1: 5 min.
before the needle-related procedure (pre-procedural pain and pre-procedural anxiety); T-2:
immediately after the needle-related procedure (post-procedural pain and post-procedural
anxiety); T-3: 15 min. after the needle-related procedure (satisfaction and feasibility
outcomes). Data analysis: Descriptive statistics will be used for group characteristics.
Quantitative multivariate analysis will be performed to compare both groups for pre- and
post-procedural pain and anxiety. Descriptive statistics will be used for report on
satisfaction and feasibility outcomes. ANCOVA will be used on covariate to increase
statistical power.
Relevance: This pilot study will assess the effects of a new device on pain and anxiety level
of immunology-rheumatology patients during needle-related procedure and will test feasibility
of the study design as well as acceptability on the new distraction device by patients and
nurses. This study will refine the research methodology and improve the intervention being
piloted for a future large-scale study.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT00527878 -
Effect of Ranitidine on Hyper-IgE Recurrent Infection (Job's) Syndrome
|
Phase 2 | |
Completed |
NCT04643639 -
Assessing the Effects of CytoSorb Hemoperfusion on the Development on Immunoparalysis
|
Phase 3 | |
Completed |
NCT05256784 -
Mountain Food and Natural Probiotic in Nutrition
|
||
Recruiting |
NCT04448951 -
Immune Homeostasis in Sepsis and Septic Shock
|
||
Recruiting |
NCT03721146 -
ENCAPSID Study : ENCApsulated Bacterial Infection and Primary, Secondary ImmunoDeficiency
|
||
Not yet recruiting |
NCT06089174 -
Assessment of the Increased Risk of Infection Following an Ultratrail
|
N/A | |
Completed |
NCT02895204 -
Effect of Fermented Maillard Reacted Whey Protein on Immune Function
|
N/A | |
Recruiting |
NCT03707782 -
Mechanisms of Immune Deficiency
|
||
Recruiting |
NCT06332196 -
Immunodeficiency and Cancer: Identification of Congenital Immune System Defects Underlying Paediatric Lymphomas
|
N/A | |
Recruiting |
NCT04646525 -
The Relationship Between Covid-19 Infection in Pediatric Patients and Secondary Lymphoid Organs
|
||
Active, not recruiting |
NCT00852943 -
Screening Protocol for Genetic Diseases of Allergic Inflammation
|
||
Completed |
NCT03609840 -
Study of Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients
|
||
Not yet recruiting |
NCT01359384 -
Bronchial Inflammation in Patients With Severe Immune Deficiency Under Immunoglobulin Treatment
|
N/A | |
Recruiting |
NCT05605808 -
Aerobic Training and Diet on the Immune System in Postmastectomy Patients Receiving Chemotherapy
|
N/A | |
Completed |
NCT03899480 -
Adoptive Transfer of Haploidentical NK Cells and N-803
|
Phase 1 | |
Completed |
NCT03051425 -
Immune Benefits of Consumption of Dairy Yogurt in Elderly
|
N/A | |
Active, not recruiting |
NCT04824651 -
Covid-19 Vaccine Cohort in Specific Populations
|
||
Enrolling by invitation |
NCT04382508 -
Coronavirus Infection in Primary or Secondary Immunosuppressed Children and Adults.
|
||
Completed |
NCT02334943 -
Immune Activation in HIV-1 Infected Patients Under AntiRetroviral Treatment
|
N/A | |
Completed |
NCT03052491 -
Effects of a 10 Component Dietary Supplement on Health and the Quality of Life
|
N/A |